Dr. Carol Baker is professor of pediatrics, McGovern Medical School at the University of Texas Health Science Center, Houston.
Dr. Baker’s clinical research has focused on all aspects of group B Streptococcus (GBS) infections from the first description of early- and late-onset sepsis and meningitis in neonates and young infants to the discovery of critical epitopes in the capsular polysaccharides necessary for development of candidate conjugate vaccine candidates. Her policy work with the American Academy of Pediatrics in the early 1990s led to the development of the first Centers for Disease Control and Prevention (CDC) recommendation in 1996 for intrapartum antibiotic prophylaxis to prevent early-onset GBS disease in neonates, a policy in its current iterations that prevents more than 80 percent of early-onset disease. Her advocacy and then leadership role at the CDC Advisory Committee on Immunization Practices (ACIP) led to the prevention of infant pertussis disease through maternal immunization with Tdap.
Dr. Baker is a member of the National Academy of Medicine, a past-president of NFID and the Infectious Diseases Society of America (IDSA), and a former chair of ACIP. Among numerous honors, she received the John P. Utz Leadership Award from NFID; the Mentor Award, Society Citation for outstanding achievements in the field of infectious disease, and the Alexander Fleming Award for Lifetime Achievement from IDSA; and the Albert Sabin Gold Medal Award from the Sabin Vaccine Institute.
Carol J. Baker, MD Presentations
June 18, 2020 at 11:30 AM - 12:30 PM
Opening Session: Now presented each year at the Annual Conference on Vaccinology Research, the Mary Lou Clements-Mann Memorial Lecture in Vaccine Sciences was initiated by NFID in 1999 to honor and remember a prolific, compassionate, and courageous vaccinologist.